You are here

  • Home
  • Archive
  • Volume 79, Issue 9
  • Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study

Article metrics

Article menu
Download PDFPDF
Epidemiology
Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study

 

Online download statistics by month:

Online download statistics by month: July 2020 to April 2025

AbstractFullPdf
Jul 202016288162074597
Aug 2020549954202078
Sep 2020476536891240
Oct 202014181359609
Nov 2020768711451
Dec 2020625576371
Jan 202138393804773
Feb 202121262093384
Mar 2021718682412
Apr 2021607582324
May 2021425397213
Jun 2021418402191
Jul 2021372359117
Aug 2021272263169
Sep 2021312279152
Oct 2021337326145
Nov 202125124498
Dec 202128726287
Jan 2022236242103
Feb 202233733096
Mar 202223522755
Apr 202218619186
May 202223323584
Jun 202221019071
Jul 202222821969
Aug 202222021833
Sep 202220620339
Oct 202217916954
Nov 202214914229
Dec 202211610520
Jan 202317917551
Feb 202314914437
Mar 202313613042
Apr 202331085
May 20231496475
Jun 202318084
Jul 2023193181
Aug 2023214150
Sep 202317271
Oct 2023256106
Nov 2023379175
Dec 2023575313
Jan 2024283266
Feb 202431283
Mar 2024233113
Apr 2024272273
May 202433695
Jun 202430130
Jul 2024566117
Aug 202423063
Sep 2024265151
Oct 202439181
Nov 2024426154
Dec 2024318384
Jan 202526192
Feb 20253441
Mar 20251480
Apr 202520180
Total503634095213353